Pablo Ruiz-Ocaña Selected Research

Antioxidants

1/2023	Altered insulin secretion dynamics relate to oxidative stress and inflammasome activation in children with obesity and insulin resistance.
1/2018	Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Ruiz-Ocaña Research Topics

Disease

3	Insulin Resistance 01/2023 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2022
2	Inflammation (Inflammations) 01/2023 - 11/2022
2	Obesity 01/2023 - 11/2022
1	Metabolic Diseases (Metabolic Disease) 11/2022
1	Overweight 11/2022
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 11/2018
1	Costello Syndrome 11/2018
1	Arteriosclerosis 11/2018
1	Hypertriglyceridemia 11/2018
1	Dyslipidemias (Dyslipidemia) 11/2018
1	Brachydactyly 01/2018
1	Aggrecan Type Spondyloepimetaphyseal Dysplasia 01/2018
1	Osteochondritis Dissecans 01/2018
1	Kimberley Type Spondyloepiphyseal Dysplasia 01/2018

Drug/Important Bio-Agent (IBA)

2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
2	AntioxidantsIBA 01/2023 - 01/2018
2	LipidsIBA 01/2023 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
1	Insulin (Novolin)FDA Link 01/2023
1	InflammasomesIBA 01/2023
1	PolyphosphatesIBA 11/2022
1	PolymersIBA 11/2022
1	Phosphates (Orthophosphate)IBA 11/2022
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 11/2018
1	Apolipoprotein C-II (ApoC2)IBA 11/2018
1	Lipoproteins (Lipoprotein)IBA 11/2018
1	Apolipoprotein A-VIBA 11/2018
1	Aggrecans (Aggrecan)IBA 01/2018